🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sibylle J. Hauske

Heidelberg University

ORCID: 0000-0003-3319-3710

Also affiliated with University Hospital Heidelberg, University Medical Centre Mannheim

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials”.

Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials

Diabetes Care(2022)10.2337/dc21-2034

N/A

1.4DataRank · unranked

44 citations

Adeera Levin, Masaomi Nangaku, Takashi Kadowaki, Rajiv Agarwal, Sibylle J. Hauske +6 more

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

Journal of the American Society of Nephrology(2023)10.1681/asn.0000000000000271

N/A

1.4DataRank · unranked

45 citations

Natalie Staplin, David Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka +25 more

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Kidney International(2020)10.1016/j.kint.2020.07.013

N/A

0.718DataRank · unranked

119 citations

Rajiv Agarwal, William G. Herrington, Hiddo J.L. Heerspink, Johannes F.E. Mann, Shahnaz Shahinfar +76 more

Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY

American Journal of Kidney Diseases(2025)10.1053/j.ajkd.2025.10.004

N/A

0.330DataRank · unranked

8 citations

Rebecca J. Sardell, Natalie Staplin, Olivier Devuyst, Daniel S. Chapman, Michael Hill +21 more